Pasture Holdings Ltd. Stock Price
Last Done:
SGD 9.39
+0.12 (+1.31%)
• Login required for live price
Open: --
High: --
Low: --
Prev Close: --
Login to unlock live stock price, change %, and intraday data.
Login to View
📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
-
- EPS Growth Range (1Y):
<0%
- Net Income Growth Range (1Y):
<0%
- Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
-
💰 Dividend History
Current year to date yield:
2.88%
📅 SGX Earnings Announcements for UUK
Pasture Holdings Ltd. (UUK)
Market: SGX |
Currency: SGD
Address: 2 Corporation
Pasture Holdings Ltd. operates as a pharmaceutical products and medical supply company in Japan, Hong Kong, Canada, Singapore, and internationally. The company operates through three segments: Pharmaceutical Wholesale and Drop-Shipment; Masks and Medical Supplies; and Other Services. It is involved in the wholesale procurement and transshipment of pharmaceutical and nutraceutical products, such as vaccines and oncology treatments; and backend support of pharmaceutical supplies to international clients' online pharmacy businesses. The company also sells surgical masks, n95 respirators, surgical n95 respirators, and n95 respirators; wound care; urology, incontinence care, and drainage; personal protective equipment; and IV therapy and vascular access. In addition, it offers oral disintegrating strips; and pet pharmaceutical and nutraceutical products and services; and furlife, a mobile application for pets. The company was founded in 1996 and is based in Singapore. Pasture Holdings Ltd. is a subsidiary of PMI Holdings Pte. Ltd.
Show more
📈 Pasture Holdings Ltd. Historical Chart
🧾 Recent Financial Statement / Corporate annoucement / News
February 13, 2026
Pasture Holdings Ltd. 1H2026 Financial Review: Navigating Headwinds in Global Pharma Pasture Holdings Ltd., a Singapore-based global pharmaceuticals and medical supplies distributor, has released its unaudited condensed interim financial statements for the six months ended 31 December 2025. The results…
February 6, 2026
Pasture Holdings Ltd (SGX: UUK): Profit Warning and Interim Outlook Analysis Pasture Holdings Ltd, a listed pharmaceutical wholesaler and distributor, has issued a profit warning for the six-month period ended 31 December 2025 (1H2026). The company expects to report a…
November 13, 2025
Pasture Holdings Ltd. AGM 2025: Key Takeaways for Investors Pasture Holdings Ltd. Annual General Meeting 2025: Comprehensive Investor Update Overview Pasture Holdings Ltd. (SGX: [Company Registration No.: 201731601W]) held its Annual General Meeting (AGM) on 23 October 2025 at Huone…
October 21, 2025
Pasture Holdings Faces Sharp Revenue Decline, Strategic Expansion, and M&A Moves Amid Regulatory Headwinds Pasture Holdings Faces Sharp Revenue Decline, Strategic Expansion, and M&A Moves Amid Regulatory Headwinds Pasture Holdings Ltd (SGX: UUK), a Singapore-based global pharmaceuticals and medical devices…
October 18, 2025
Pasture Holdings Issues Key Corrections to Annual Report 2025: Shareholders Urged to Note Financial and Leadership Updates Pasture Holdings Issues Key Corrections to Annual Report 2025: Shareholders Urged to Note Financial and Leadership Updates Key Highlights and Investor-Relevant Corrections Pasture…
August 26, 2025
Pasture Holdings Ltd. FY2025 Financial Results: A Detailed Analysis Pasture Holdings Ltd., a Singapore-listed healthcare and pharmaceutical company, has released its unaudited consolidated financial statements for the full year ended June 30, 2025. The results reflect both resilience and challenges…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Research Reports
usort($results_posts, function($a, $b) {
return get_post_time('U', true, $b) - get_post_time('U', true, $a);
});
?>
No related articles found.
